NSC |
Compound |
Enrichment |
Correlation |
NSC 119754 |
Berbinium, 7,8,13,13a-tetradehydro-2,3:9,10-bis(methylenedioxy)-, chloride (8CI) |
0.0105972823829604 |
0.30812706 |
NSC 120925 |
Null |
0.0105972823829604 |
0.27837135 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0105972823829604 |
-0.059422495 |
NSC 285116 |
17H,26H-4a,28-(Iminoethaniminoethanimino ethaniminoethanimino[7,2]quinolinomethanoxy methano)-8,5:18,15:25,22:32,29-tetranitrilo-4H,15H-pyrido[3,2-m][1,11,17,24,4,7,20,27] tetrathiatetraazacyclotriac |
0.0105972823829604 |
0.29662836 |
NSC 31780 |
3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) |
0.0105972823829604 |
0.3479261 |
NSC 319947 |
2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)-6-ethyl- |
0.0105972823829604 |
0.040121712 |
NSC 615538 |
ANTINEOPLASTIC-615538 |
0.0105972823829604 |
0.55842434 |
NSC 617768 |
Null |
0.0105972823829604 |
0.29907443 |
NSC 618770 |
Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide |
0.0105972823829604 |
0.29923154 |
NSC 620109 |
Propanoic acid, 3-bromo-2-(bromomethyl)-, methyl ester |
0.0105972823829604 |
0.32524361 |